Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Commentary · January 19, 2023

Scientists Tie Third Clinical Trial Death to Lecanemab, an Experimental Drug for Alzheimer’s Disease

Science (New York, N.Y.)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Science (New York, N.Y.)
Scientists tie third clinical trial death to experimental Alzheimer’s drug
Science 2022 Dec 21;[EPub Ahead of Print], C Piller

Further Reading